查看購物車
  • Simplified Chinese
  • English
  • Japanese
全球醫療保健品管(QMS) 市場按產品、功能、用例、最終用戶和地區分類－預測至 2030 年
市場調查報告書
商品編碼
1854899

全球醫療保健品管(QMS) 市場按產品、功能、用例、最終用戶和地區分類－預測至 2030 年

Healthcare Quality Management (QMS) Market by Offering (Software (Integrated), Service), Function (Compliance, Risk, Audit, CAPA, Change), Use Case (Quality, Analytics, Performance, Regulatory), End User (Hospital, ASC, Payer) - Global Forecast to 2030
出版日期: | 出版商: MarketsandMarkets | 英文 355 Pages | 訂單完成後即時交付

價格

全球醫療保健品管(QMS) 市場規模預計將從 2025 年的 14.2 億美元成長到 2030 年的 25.1 億美元，預測期內複合年成長率高達 12.1%。

由於對病人安全、臨床品質和結果透明度的日益重視，醫療品管(QMS) 市場正在穩步發展。不斷提高的監管要求和政府為提升醫療標準所採取的舉措，正促使醫療服務提供者採用結構化的品管解決方案。這些系統使醫院和醫療機構能夠追蹤績效指標、管理風險、確保合規性並簡化報告流程。

調查範圍
調查年度 2024-2030
基準年 2024
預測期 2025-2030
考慮單位 金額（十億美元）
部分 透過產品/服務、功能、用例、最終用戶和區域進行分類
目標區域 北美洲、歐洲、亞太地區、中東和非洲、拉丁美洲

然而，儘管市場需求強勁，但該行業仍面臨持續的挑戰，其中最主要的是數據品質問題以及不同醫療資訊系統之間的碎片化，這些問題阻礙了無縫整合和洞察生成。解決這些障礙對於實現更安全、更有效率、更課責的醫療保健市場承諾至關重要。

醫療保健品質管理（QMS）市場-IMG1

商業智慧(BI) 和分析領域在醫療品管(QMS) 市場中佔據最大佔有率，預計未來幾年將繼續保持領先地位。這一主導地位源於醫療機構對數據主導決策、預測性洞察和績效最佳化的日益成長的需求。 BI 和分析解決方案使醫療服務提供者、支付方和管理人員能夠即時分析臨床、財務和營運數據，從而支援主動品質改進和合規性。借助高級分析技術，醫療機構可以識別護理缺口、監測患者預後、最佳化資源分配，並最終提高效率和病人安全。基於價值的醫療模式的日益普及以及向個人化醫療的轉變進一步推動了對 BI主導洞察的需求。此外，與雲端平台的整合以及跨不同醫療 IT 系統的互通性增強了擴充性和協作性。隨著醫療相關人員繼續優先考慮可衡量的品質結果和成本最佳化，BI 和分析將繼續成為關鍵應用場景，從而鞏固其市場領導地位。

在預測期內，軟體領域預計將成為醫療品管(QMS) 市場中成長最快的部分。這一成長主要得益於對擴充性、專業化和靈活解決方案日益成長的需求，這些解決方案能夠簡化品管功能，例如合規性報告、風險評估、事件追蹤、績效監控和病患安全管理。軟體解決方案使醫療機構能夠實現工作流程自動化、減輕管理負擔，並提供品質指標的即時可見性，從而支援跨職能、數據主導的決策。透過集中化和標準化流程，這些解決方案能夠最大限度地減少錯誤，並確保符合不斷變化的監管要求。雲端基礎平台、電子病歷 (EHR) 整合和進階分析功能的日益普及，進一步加速了軟體的採用。隨著醫療服務提供者致力於提高醫療品質、營運效率和合規性，預計軟體產品將在預測期內推動市場顯著成長。

預計亞太地區將在預測期內實現醫療品管（QMS）市場最快的成長。這一成長主要得益於各國政府為加強醫療體係而不斷加大投入、對數位醫療技術的投資日益成長，以及監管機構對病人安全和臨床品質的關注度不斷提高。醫療基礎設施的快速擴張，尤其是在印度和中國等新興經濟體，正在推動對先進品管解決方案的需求。該地區日益加重的慢性病負擔和人口老化進一步加劇了對強大平台的需求，這些平台能夠追蹤治療結果、減少醫療差錯並提高醫療服務效率。此外，雲端基礎醫療IT解決方案的日益普及以及本地醫療機構與全球技術供應商之間合作的不斷深化，也促進了整合品管系統的快速部署。這些因素共同作用，使亞太地區成為成長最快的區域市場，並在塑造全球醫療品管（QMS）的未來方面發揮關鍵作用。

本報告對全球醫療保健品管(QMS) 市場進行了分析，從產品、功能、用例、最終用戶和地理趨勢等方面對其進行了細分，並對參與該市場的公司進行了概況介紹。

目錄

第1章 引言

第2章調查方法

第3章執行摘要

第4章重要考察

第5章 市場概覽

  • 介紹
  • 市場動態
  • 影響客戶業務的趨勢/顛覆性因素
  • 產業趨勢
  • 定價分析
  • 價值鏈分析
  • 生態系分析
  • 投資和資金籌措方案
  • 技術分析
  • 專利分析
  • 2025-2026 年主要會議和活動
  • 案例研究分析
  • 監管分析
  • 波特五力分析
  • 主要相關人員和採購標準
  • 未滿足需求分析
  • 經營模式分析
  • 人工智慧/生成式人工智慧對醫療保健品管（QMS）市場的影響
  • 2025年美國關稅對醫療保健品管（QMS）市場的影響

6. 醫療保健品管(QMS) 市場，依產品/服務分類

  • 介紹
  • 軟體
  • 服務

7. 醫療保健品管（QMS）市場，依功能分類

  • 介紹
  • 文件管理
  • 風險管理
  • 審核管理
  • CAPA 和不符合項管理
  • 變革管理
  • 申訴管理
  • 培訓管理
  • 其他

8. 醫療保健品管(QMS) 市場，依用例分類

  • 介紹
  • 品質報告
  • 商業智慧和分析
  • 臨床風險管理
  • 供應商績效管理
  • 監管和認證合規性
  • 病患體驗與參與

9. 醫療保健品管(QMS) 市場（按最終用戶分類）

  • 介紹
  • 醫療保健提供者
  • 醫療保健支付方

第10章 醫療保健品管（QMS）市場（按地區分類）

  • 介紹
  • 北美洲
    • 北美宏觀經濟展望
    • 美國
    • 加拿大
  • 歐洲
    • 歐洲宏觀經濟展望
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 其他
  • 亞太地區
    • 亞太宏觀經濟展望
    • 日本
    • 中國
    • 印度
    • 韓國
    • 澳洲
    • 其他
  • 拉丁美洲
    • 拉丁美洲宏觀經濟展望
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲
    • 中東和非洲宏觀經濟展望
    • 海灣合作理事會國家
    • 其他

第11章 競爭格局

  • 概述
  • 主要參與企業的策略/優勢
  • 2020-2024年收益分析
  • 2024年市佔率分析
  • 品牌/產品對比
  • 估值和財務指標
  • 公司估值矩陣：主要參與企業，2024 年
  • 公司估值矩陣：Start-Ups/中小企業，2024 年
  • 競爭場景

第12章：公司簡介

  • 主要參與企業
    • NUANCE COMMUNICATIONS, INC.（MICROSOFT）
    • PREMIER INC.
    • OPTUM, INC.（UNITEDHEALTH GROUP）
    • INTELEX TECHNOLOGIES（FORTIVE）
    • DNV
    • RLDATIX
    • RISKONNECT, INC.
    • HCI
    • IDEAGEN
    • MEDISOLV, INC.
    • VALENZ HEALTH
    • ODITEK SOLUTIONS
    • THE PATIENT SAFETY COMPANY（TPSC）
    • MORCARE
    • YOUCOMPLY, LTD.（VICLARITY）
    • SIMPLERQMS
    • NAVEX GLOBAL, INC.（GOLDMAN SACHS）
    • PROVIDERTRUST
    • MEDTRAINER
  • 其他公司
    • OKKALA SOLUTIONS PRIVATE LIMITED
    • SAFEQUAL
    • EFFIVITY TECHNOLOGIES, INC.
    • TITLE21 HEALTH SOLUTIONS
    • MEDBLAZE（INFINI）
    • ETASKPRO
    • QUALITYZE
    • KARMINN CONSULTANCY NETWORK
    • MEG

第13章附錄

Product Code: HIT 5473

The global healthcare quality management (QMS) market is projected to reach USD 2.51 billion by 2030 from USD 1.42 billion in 2025, at a high CAGR of 12.1% during the forecast period. The healthcare quality management (QMS) market is progressing steadily, driven by the growing emphasis on patient safety, clinical quality, and outcome transparency. Rising regulatory requirements and government initiatives aimed at improving care standards are pushing providers to adopt structured quality management solutions. These systems enable hospitals and healthcare organizations to track performance metrics, manage risks, ensure compliance, and streamline reporting processes.

Scope of the Report
Years Considered for the Study2024-2030
Base Year2024
Forecast Period2025-2030
Units ConsideredValue (USD billion)
SegmentsOffering, Function, Use case, End User, and Region
Regions coveredNorth America, Europe, Asia Pacific, Middle East & Africa, and Latin America

However, despite strong adoption drivers, the sector faces persistent challenges. Chief among them are data quality and fragmentation across diverse healthcare IT systems, which hinder seamless integration and insights generation, along with the high implementation and maintenance costs of quality management platforms. Addressing these barriers will be crucial for the market to deliver on its promise of safer, more efficient, and accountable healthcare delivery.

Healthcare Quality Management (QMS) Market - IMG1

"By use case, the business intelligence & analytics segment is the largest segment during the forecast period."

The business intelligence (BI) & analytics segment accounts for the largest share of the healthcare quality management (QMS) market and is projected to maintain its lead in the coming years. This dominance is driven by the increasing need for data-driven decision-making, predictive insights, and performance optimization in healthcare organizations. BI and analytics solutions enable providers, payers, and administrators to analyze clinical, financial, and operational data in real time, supporting proactive quality improvement and regulatory compliance. By leveraging advanced analytics, healthcare institutions can identify care gaps, monitor patient outcomes, and streamline resource allocation, ultimately improving both efficiency and patient safety. The growing adoption of value-based care models and the shift toward personalized medicine further strengthen demand for BI-driven insights. Moreover, integration with cloud platforms and interoperability across diverse health IT systems enhances scalability and collaboration. As healthcare stakeholders continue to prioritize measurable quality outcomes and cost optimization, BI & analytics will remain the cornerstone use case, reinforcing its market leadership.

"By offering, the software segment is expected to register the fastest growth in the healthcare quality management (QMS) market during the forecast period."

The software segment is expected to register the fastest growth in the healthcare quality management (QMS) market during the forecast period. This growth is driven by the rising demand for scalable, specialized, and flexible solutions that streamline quality management functions such as compliance reporting, risk assessment, incident tracking, performance monitoring, and patient safety management. Software solutions help healthcare organizations automate workflows, reduce administrative burden, and provide real-time visibility into quality metrics, enabling data-driven decision-making across departments. By centralizing and standardizing processes, these solutions minimize errors and ensure alignment with evolving regulatory requirements. The increasing adoption of cloud-based platforms, integration with EHRs, and advanced analytics capabilities are further accelerating software deployment. As healthcare providers focus on improving care quality, operational efficiency, and regulatory compliance, software offerings are poised to drive significant growth in the market over the forecast period.

"The Asia Pacific is expected to witness the highest growth rate during the forecast period."

The Asia Pacific region is expected to register the fastest growth in the healthcare quality management (QMS) market over the forecast period. This growth is supported by rising government initiatives to strengthen healthcare systems, increasing investments in digital health technologies, and greater regulatory focus on patient safety and clinical quality. Rapid expansion of healthcare infrastructure, particularly in emerging economies such as India and China, is driving demand for advanced quality management solutions. The region's growing chronic disease burden and aging population are further accelerating the need for robust platforms to track outcomes, reduce medical errors, and enhance efficiency in care delivery. Additionally, the increasing adoption of cloud-based healthcare IT solutions and growing collaborations between local providers and global technology vendors are enabling faster deployment of integrated quality management systems. Together, these factors position the Asia Pacific as the fastest-growing regional market, playing a pivotal role in shaping the future of healthcare quality management (QMS) worldwide.

In-depth interviews have been conducted with chief executive officers (CEOs), Directors, and other executives from various key organizations operating in the authentication and brand protection marketplace. The breakdown of primary participants is as mentioned below:

  • By Company Type: Tier 1 (48%), Tier 2 (36%), and Tier 3 (16%)
  • By Designation: Directors (15%), Managers (10%), and Others (75%)
  • By Region: North America (39%), Europe (31%), Asia Pacific (21%), Latin America (6%), and the Middle East & Africa (3%)

Key Players in the Healthcare Quality Management (QMS) Market

The key players operating in the healthcare quality management (QMS) market include Nuance Communications, Inc. (US), Premier Inc. (US), Optum, Inc. (US), Intelex Technologies (Canada), DNV (Norway), RLDatix (US), Riskonnect, Inc. (US), HCI (Ireland), Ideagen (UK), Medisolv, Inc. (US), Valenz Health (US), OdiTek Solutions (India), The Patient Safety Company (TPSC) (Netherlands), MorCare (Harris Health) (US), YouComply, Ltd. (ViClarity) (UK), SimplerQMS (US), NAVEX Global, Inc. (US), ProviderTrust (US), MedTrainer (US), OKKALA SOLUTIONS PRIVATE LIMITED (India), SafeQual (US), Effivity Technologies, Inc. (US), Title21 Health Solutions (US), Medblaze (INFINI) (India), eTaskPro (UAE), Qualityze (US), Karminn Consultancy Network (India), and MEG (Ireland).

Research Coverage:

The report analyzes the healthcare quality management (QMS) market and aims to estimate the market size and future growth potential of various market segments, based on offering, function, use case, end user, and region. The report also provides a competitive analysis of the key players operating in this market, along with their company profiles, product offerings, recent developments, and key market strategies.

Reasons to Buy the Report

This report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them garner a greater share of the market. Firms purchasing the report could use one or a combination of the below-mentioned strategies to strengthen their positions in the market.

This report provides insights into:

  • Analysis of key drivers (rising adoption of AI, ML, and predictive analytics in healthcare; increasing focus on patient safety and clinical quality; interoperability of health data & health information exchange; and growing regulatory requirements and government initiatives), restraints (data quality and fragmentation challenges across healthcare IT systems and high implementation and maintenance costs of quality management systems), opportunities (integration with patient-generated health data (PGHD) and voice and NLP for quality documentation), and challenges (data privacy and security concerns, standardization of quality measures & data models, and limited skilled workforce & training gaps) influencing the growth of the healthcare quality management (QMS) market.
  • Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product & service launches in the healthcare quality management (QMS) market.
  • Market Development: Comprehensive information on the lucrative emerging markets, offering, function, use case, end user, and region.
  • Market Diversification: Exhaustive information about the product portfolios, growing geographies, recent developments, and investments in the healthcare quality management (QMS) market
  • Competitive Assessment: In-depth assessment of market shares, growth strategies, product offerings, and capabilities of the leading players in the healthcare quality management (QMS) market, like Nuance Communications, Inc. (US), Premier Inc. (US), Optum, Inc. (US), RLDatix (US), and Intelex Technologies (Canada).

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 STUDY OBJECTIVES
  • 1.2 MARKET DEFINITION
  • 1.3 STUDY SCOPE
    • 1.3.1 MARKET SEGMENTATION & REGIONAL SCOPE
    • 1.3.2 INCLUSIONS & EXCLUSIONS
    • 1.3.3 YEARS CONSIDERED
  • 1.4 CURRENCY CONSIDERED
  • 1.5 LIMITATIONS
    • 1.5.1 METHODOLOGY-RELATED LIMITATIONS
    • 1.5.2 SCOPE-RELATED LIMITATIONS
  • 1.6 MARKET STAKEHOLDERS
  • 1.7 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY

  • 2.1 RESEARCH APPROACH
    • 2.1.1 SECONDARY RESEARCH
      • 2.1.1.1 Key data from secondary sources
    • 2.1.2 PRIMARY RESEARCH
      • 2.1.2.1 Primary sources
      • 2.1.2.2 Key data from primary sources
      • 2.1.2.3 Breakdown of primaries
      • 2.1.2.4 Insights from primary experts
  • 2.2 RESEARCH METHODOLOGY DESIGN
  • 2.3 MARKET SIZE ESTIMATION
  • 2.4 MARKET BREAKDOWN & DATA TRIANGULATION
  • 2.5 MARKET SHARE ESTIMATION
  • 2.6 STUDY ASSUMPTIONS
  • 2.7 RESEARCH LIMITATIONS
    • 2.7.1 METHODOLOGY-RELATED LIMITATIONS
  • 2.8 RISK ASSESSMENT

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

  • 4.1 OPPORTUNITIES FOR PLAYERS IN HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET
  • 4.2 NORTH AMERICA: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY OFFERING & COUNTRY
  • 4.3 HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
  • 4.4 HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET: REGIONAL MIX (2023-2030)
  • 4.5 HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET: DEVELOPED VS. EMERGING ECONOMIES, 2025 VS. 2030 (USD MILLION)

5 MARKET OVERVIEW

  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    • 5.2.1 DRIVERS
      • 5.2.1.1 Rising adoption of AI, ML, and predictive analytics in healthcare
      • 5.2.1.2 Increasing focus on patient safety and clinical quality
      • 5.2.1.3 Interoperability of health data & health information exchange
      • 5.2.1.4 Growing regulatory requirements and government initiatives
    • 5.2.2 RESTRAINTS
      • 5.2.2.1 Data quality and fragmentation challenges across healthcare IT systems
      • 5.2.2.2 High implementation and maintenance costs of quality management systems
    • 5.2.3 OPPORTUNITIES
      • 5.2.3.1 Integration with patient-generated health data (PGHD)
      • 5.2.3.2 Voice and NLP for quality documentation
    • 5.2.4 CHALLENGES
      • 5.2.4.1 Data privacy and security concerns
      • 5.2.4.2 Standardization of quality measures & data models
      • 5.2.4.3 Limited skilled workforce & training gaps
  • 5.3 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
  • 5.4 INDUSTRY TRENDS
    • 5.4.1 AI-DRIVEN PREDICTIVE ANALYTICS
    • 5.4.2 INTEGRATION OF CLOUD-BASED QUALITY MANAGEMENT SOLUTIONS
    • 5.4.3 EMPHASIS ON PATIENT-CENTERED CARE
    • 5.4.4 REGULATORY COMPLIANCE AND RISK MANAGEMENT
    • 5.4.5 CROSS-INDUSTRY COLLABORATION FOR INNOVATION
  • 5.5 PRICING ANALYSIS
    • 5.5.1 INDICATIVE PRICING OF HEALTHCARE QUALITY MANAGEMENT (QMS) SOLUTIONS, BY KEY PLAYER (2024)
    • 5.5.2 INDICATIVE PRICING OF HEALTHCARE QUALITY MANAGEMENT (QMS) SOLUTIONS, BY REGION (2024)
    • 5.5.3 PRICING MODELS (QUALITATIVE)
  • 5.6 VALUE CHAIN ANALYSIS
    • 5.6.1 PRODUCT DESIGN & DEVELOPMENT
    • 5.6.2 SYSTEM INTEGRATION & WORKFLOW CUSTOMIZATION
    • 5.6.3 IMPLEMENTATION
    • 5.6.4 QUALITY ANALYTICS & REPORTING INSIGHTS
    • 5.6.5 POST-SALES SERVICES
  • 5.7 ECOSYSTEM ANALYSIS
  • 5.8 INVESTMENT & FUNDING SCENARIO
  • 5.9 TECHNOLOGY ANALYSIS
    • 5.9.1 KEY TECHNOLOGIES
      • 5.9.1.1 Quality measurement & reporting platforms
      • 5.9.1.2 Performance & benchmarking analytics tools
      • 5.9.1.3 Business intelligence (BI) & advanced analytics
    • 5.9.2 COMPLEMENTARY TECHNOLOGIES
      • 5.9.2.1 Interoperability/Health information exchange (HIE)/FHIR APIs
      • 5.9.2.2 Telehealth & remote patient monitoring (RPM)
      • 5.9.2.3 Data integration/Enterprise data warehouses & master data management
    • 5.9.3 ADJACENT TECHNOLOGIES
      • 5.9.3.1 Patient engagement platforms & portals (PROs)
      • 5.9.3.2 Clinical documentation improvement (CDI) & coding/RCM systems
      • 5.9.3.3 Automation & ambient clinician support (RPA, Voice/AI Scribing)
  • 5.10 PATENT ANALYSIS
  • 5.11 KEY CONFERENCES & EVENTS, 2025-2026
  • 5.12 CASE STUDY ANALYSIS
    • 5.12.1 CASE STUDY 1: DRIVING COST SAVINGS AND CARE QUALITY THROUGH UNIFIED DATA AND ANALYTICS
    • 5.12.2 CASE STUDY 2: BOOSTING ACCURACY AND COMPLIANCE WITH AUTOMATED QUALITY REPORTING
    • 5.12.3 CASE STUDY 3: IMPROVING CARE HOME COMPLIANCE AND OPERATIONAL EFFICIENCY THROUGH AUTOMATED QUALITY MANAGEMENT
  • 5.13 REGULATORY ANALYSIS
    • 5.13.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    • 5.13.2 REGULATORY LANDSCAPE
      • 5.13.2.1 North America
      • 5.13.2.2 Europe
      • 5.13.2.3 Asia Pacific
      • 5.13.2.4 Middle East & Africa
      • 5.13.2.5 Latin America
  • 5.14 PORTER'S FIVE FORCES ANALYSIS
    • 5.14.1 BARGAINING POWER OF SUPPLIERS
    • 5.14.2 BARGAINING POWER OF BUYERS
    • 5.14.3 THREAT OF NEW ENTRANTS
    • 5.14.4 THREAT OF SUBSTITUTES
    • 5.14.5 INTENSITY OF COMPETITIVE RIVALRY
  • 5.15 KEY STAKEHOLDERS & BUYING CRITERIA
    • 5.15.1 KEY STAKEHOLDERS IN BUYING PROCESS
    • 5.15.2 BUYING CRITERIA
  • 5.16 UNMET NEEDS ANALYSIS
    • 5.16.1 CURRENT UNMET NEEDS
    • 5.16.2 END-USER EXPECTATIONS
  • 5.17 BUSINESS MODEL ANALYSIS
    • 5.17.1 SUBSCRIPTION-BASED (SAAS) MODEL
    • 5.17.2 LICENSING & PERPETUAL SOFTWARE MODEL
    • 5.17.3 PAY-PER-USE/TRANSACTION-BASED MODEL
    • 5.17.4 ANALYTICS & BENCHMARKING SERVICES MODEL
    • 5.17.5 QUALITY TRANSFORMATION & CONSULTING MODEL
  • 5.18 IMPACT OF AI/GEN AI ON HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET
    • 5.18.1 INTRODUCTION
    • 5.18.2 MARKET POTENTIAL OF AI/GEN AI IN HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET
    • 5.18.3 CASE STUDIES RELATED TO AI/GEN AI IMPLEMENTATION
      • 5.18.3.1 Transforming healthcare quality management (QMS) with AI-powered virtual care platforms
    • 5.18.4 IMPACT OF AI/GEN AI ON INTERCONNECTED AND ADJACENT ECOSYSTEMS
      • 5.18.4.1 Patient engagement solutions
      • 5.18.4.2 Population health management
      • 5.18.4.3 Patient safety software
    • 5.18.5 USER READINESS AND IMPACT ASSESSMENT
      • 5.18.5.1 User readiness
        • 5.18.5.1.1 User A: Hospitals
        • 5.18.5.1.2 User B: Outpatient & ambulatory care centers
      • 5.18.5.2 Impact assessment
        • 5.18.5.2.1 User A: Hospitals
        • 5.18.5.2.2 User B: Outpatient & ambulatory care centers
  • 5.19 IMPACT OF 2025 US TARIFFS ON HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET
    • 5.19.1 INTRODUCTION
    • 5.19.2 KEY TARIFF RATES
    • 5.19.3 PRICE IMPACT ANALYSIS
    • 5.19.4 IMPACT ON COUNTRY/REGION
      • 5.19.4.1 US
      • 5.19.4.2 Europe
      • 5.19.4.3 Asia Pacific
    • 5.19.5 IMPACT ON END-USE INDUSTRIES
      • 5.19.5.1 Healthcare providers
      • 5.19.5.2 Healthcare payers

6 HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY OFFERING

  • 6.1 INTRODUCTION
  • 6.2 SOFTWARE
    • 6.2.1 INTEGRATED SUITES
      • 6.2.1.1 Increasing need for platforms to manage quality across entire care continuum to drive demand for integrated suites
    • 6.2.2 POINT SOLUTIONS
      • 6.2.2.1 Growing need for targeted tools that address specific challenges without need for enterprise-wide deployment to drive market
  • 6.3 SERVICES
    • 6.3.1 IMPLEMENTATION & TRAINING
      • 6.3.1.1 Structured deployment and workforce training associated with implementation & training services to boost market
    • 6.3.2 SUPPORT SERVICES
      • 6.3.2.1 Ongoing technical assistance ensuring reliable performance of healthcare quality management (QMS) systems to support growth
    • 6.3.3 CONSULTING SERVICES
      • 6.3.3.1 Benefits such as strategic advisory and process optimization to drive demand for consulting services
    • 6.3.4 OTHER SERVICES

7 HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY FUNCTION

  • 7.1 INTRODUCTION
  • 7.2 DOCUMENT MANAGEMENT
    • 7.2.1 ADVANTAGES SUCH AS STANDARDIZED CLINICAL AND OPERATIONAL WORKFLOWS AND RELIABLE AUDIT TRAILS TO DRIVE DEMAND
  • 7.3 RISK MANAGEMENT
    • 7.3.1 RISING ADOPTION OF RISK MANAGEMENT SOLUTIONS FOR IMPROVING PATIENT SAFETY AND COMPLIANCE TO DRIVE GROWTH
  • 7.4 AUDIT MANAGEMENT
    • 7.4.1 GROWING ADOPTION OF AUDIT MANAGEMENT SYSTEMS TO ENHANCE OPERATIONAL EFFICIENCY TO SUPPORT MARKET
  • 7.5 CAPA & NONCONFORMANCE MANAGEMENT
    • 7.5.1 GROWING NEED FOR CAPA & NONCONFORMANCE MANAGEMENT TO ENHANCE HEALTHCARE QUALITY AND COMPLIANCE TO FUEL GROWTH
  • 7.6 CHANGE MANAGEMENT
    • 7.6.1 RISING ADOPTION OF CHANGE MANAGEMENT SOLUTIONS TO STRENGTHEN COMPLIANCE AND QUALITY TO BOOST MARKET
  • 7.7 COMPLAINT MANAGEMENT
    • 7.7.1 GROWING USE OF COMPLAINT MANAGEMENT SYSTEMS TO STRENGTHEN PATIENT SAFETY AND REGULATORY COMPLIANCE TO PROPEL MARKET
  • 7.8 TRAINING MANAGEMENT
    • 7.8.1 STRENGTHENING WORKFORCE READINESS WITH TRAINING MANAGEMENT TOOLS TO CONTRIBUTE TO MARKET GROWTH
  • 7.9 OTHER FUNCTIONS

8 HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY USE CASE

  • 8.1 INTRODUCTION
  • 8.2 QUALITY REPORTING
    • 8.2.1 ADVANTAGES SUCH AS STRUCTURED COLLECTION AND ANALYSIS OF PHYSICIAN PERFORMANCE TO BOOST MARKET
  • 8.3 BUSINESS INTELLIGENCE & ANALYTICS
    • 8.3.1 DEPLOYMENT OF ADVANCED ANALYTICS TO STRENGTHEN EFFICIENCY AND ACCOUNTABILITY TO DRIVE GROWTH
  • 8.4 CLINICAL RISK MANAGEMENT
    • 8.4.1 ADOPTION OF CLINICAL RISK MANAGEMENT TO ENHANCE PATIENT SAFETY, CARE QUALITY, AND ORGANIZATIONAL RESILIENCE
  • 8.5 PROVIDER PERFORMANCE MANAGEMENT
    • 8.5.1 OPTIMIZING CLINICIAN AND NETWORK PERFORMANCE THROUGH DATA-DRIVEN QUALITY MANAGEMENT IN HEALTHCARE TO SUPPORT GROWTH
  • 8.6 REGULATORY & ACCREDITATION COMPLIANCE
    • 8.6.1 ENHANCING HEALTHCARE QUALITY THROUGH PROACTIVE REGULATORY AND ACCREDITATION COMPLIANCE MANAGEMENT TO DRIVE MARKET
  • 8.7 PATIENT EXPERIENCE & ENGAGEMENT
    • 8.7.1 ENHANCING PATIENT EXPERIENCE AND ENGAGEMENT TO STRENGTHEN CARE QUALITY AND OPERATIONAL PERFORMANCE TO PROPEL MARKET

9 HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY END USER

  • 9.1 INTRODUCTION
  • 9.2 HEALTHCARE PROVIDERS
    • 9.2.1 HOSPITALS
      • 9.2.1.1 Growing implementation of standardized care protocols and compliance measures to drive demand
    • 9.2.2 OUTPATIENT & AMBULATORY CARE CENTERS
      • 9.2.2.1 Growing need to streamline workflows and improve patient access to boost market
    • 9.2.3 PHYSICIAN & GROUP PRACTICES
      • 9.2.3.1 Ability to enhance care coordination and performance tracking to drive adoption
    • 9.2.4 LONG-TERM CARE & POST-ACUTE FACILITIES
      • 9.2.4.1 Benefits such as optimized patient safety and operational efficiency to fuel growth
    • 9.2.5 OTHER HEALTHCARE PROVIDERS
  • 9.3 HEALTHCARE PAYERS
    • 9.3.1 PUBLIC PAYERS
      • 9.3.1.1 Leveraging data-driven insights to improve population health and ensure compliance to support growth
    • 9.3.2 PRIVATE PAYERS
      • 9.3.2.1 Ability of tools to track outcomes, identify care gaps, and optimize interventions to boost demand

10 HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY REGION

  • 10.1 INTRODUCTION
  • 10.2 NORTH AMERICA
    • 10.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA
    • 10.2.2 US
      • 10.2.2.1 US to dominate global market for healthcare quality management (QMS)
    • 10.2.3 CANADA
      • 10.2.3.1 Growing government support and digital health adoption to fuel market growth
  • 10.3 EUROPE
    • 10.3.1 MACROECONOMIC OUTLOOK FOR EUROPE
    • 10.3.2 UK
      • 10.3.2.1 Growing digital health infrastructure and clinical innovation to fuel market growth
    • 10.3.3 GERMANY
      • 10.3.3.1 Operational and regulatory challenges in Germany's healthcare quality management (QMS) market to limit growth
    • 10.3.4 FRANCE
      • 10.3.4.1 National quality strategies and hospital modernization to fuel market adoption
    • 10.3.5 ITALY
      • 10.3.5.1 Challenges and regional disparities in Italy's healthcare quality management (QMS) market to hinder growth
    • 10.3.6 SPAIN
      • 10.3.6.1 Value-based care reforms and digital reporting to drive Spain's healthcare quality management (QMS) market
    • 10.3.7 REST OF EUROPE
  • 10.4 ASIA PACIFIC
    • 10.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
    • 10.4.2 JAPAN
      • 10.4.2.1 Integration of AI regulations to enhance healthcare quality management (QMS) in Japan
    • 10.4.3 CHINA
      • 10.4.3.1 Challenges and operational barriers in China's healthcare quality management (QMS) market to limit growth
    • 10.4.4 INDIA
      • 10.4.4.1 Public health reforms and regulatory oversight to drive growth in India's healthcare quality management (QMS) market
    • 10.4.5 SOUTH KOREA
      • 10.4.5.1 Digital transformation to drive healthcare quality management (QMS) market in South Korea
    • 10.4.6 AUSTRALIA
      • 10.4.6.1 Workforce shortages and varying levels of staff training to hinder market growth
    • 10.4.7 REST OF ASIA PACIFIC
  • 10.5 LATIN AMERICA
    • 10.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA
    • 10.5.2 BRAZIL
      • 10.5.2.1 Brazil to dominate healthcare quality management (QMS) market in Latin America
    • 10.5.3 MEXICO
      • 10.5.3.1 Mexico to emerge as key healthcare quality management (QMS) market in Latin America
    • 10.5.4 REST OF LATIN AMERICA
  • 10.6 MIDDLE EAST & AFRICA
    • 10.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA
    • 10.6.2 GCC COUNTRIES
      • 10.6.2.1 Saudi Arabia
        • 10.6.2.1.1 Regulatory reforms and Vision 2030 investments to support market growth
      • 10.6.2.2 UAE
        • 10.6.2.2.1 Accreditation and patient safety initiatives to drive market growth
      • 10.6.2.3 Rest of Gcc Countries
    • 10.6.3 REST OF MIDDLE EAST & AFRICA

11 COMPETITIVE LANDSCAPE

  • 11.1 OVERVIEW
  • 11.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
    • 11.2.1 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET
  • 11.3 REVENUE ANALYSIS, 2020-2024
  • 11.4 MARKET SHARE ANALYSIS, 2024
  • 11.5 BRAND/PRODUCT COMPARISON
  • 11.6 COMPANY VALUATION & FINANCIAL METRICS
    • 11.6.1 FINANCIAL METRICS
    • 11.6.2 COMPANY VALUATION
  • 11.7 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024
    • 11.7.1 STARS
    • 11.7.2 EMERGING LEADERS
    • 11.7.3 PERVASIVE PLAYERS
    • 11.7.4 PARTICIPANTS
    • 11.7.5 COMPANY FOOTPRINT: KEY PLAYERS, 2024
      • 11.7.5.1 Company footprint
      • 11.7.5.2 Region footprint
      • 11.7.5.3 Offering footprint
      • 11.7.5.4 Function footprint
      • 11.7.5.5 Use case footprint
      • 11.7.5.6 End-user footprint
  • 11.8 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024
    • 11.8.1 PROGRESSIVE COMPANIES
    • 11.8.2 RESPONSIVE COMPANIES
    • 11.8.3 DYNAMIC COMPANIES
    • 11.8.4 STARTING BLOCKS
    • 11.8.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024
      • 11.8.5.1 Detailed list of key startups/SMEs
      • 11.8.5.2 Competitive benchmarking of startups/SMEs
  • 11.9 COMPETITIVE SCENARIO
    • 11.9.1 PRODUCT LAUNCHES & ENHANCEMENTS
    • 11.9.2 DEALS
    • 11.9.3 OTHER DEVELOPMENTS

12 COMPANY PROFILES

  • 12.1 KEY PLAYERS
    • 12.1.1 NUANCE COMMUNICATIONS, INC. (MICROSOFT)
      • 12.1.1.1 Business overview
      • 12.1.1.2 Products & services offered
      • 12.1.1.3 Recent developments
        • 12.1.1.3.1 Deals
      • 12.1.1.4 MnM view
        • 12.1.1.4.1 Right to win
        • 12.1.1.4.2 Strategic choices
        • 12.1.1.4.3 Weaknesses & competitive threats
    • 12.1.2 PREMIER INC.
      • 12.1.2.1 Business overview
        • 12.1.2.1.1 Products & services offered
      • 12.1.2.2 Recent developments
        • 12.1.2.2.1 Product enhancements
        • 12.1.2.2.2 Deals
      • 12.1.2.3 MnM view
        • 12.1.2.3.1 Right to win
        • 12.1.2.3.2 Strategic choices
        • 12.1.2.3.3 Weaknesses & competitive threats
    • 12.1.3 OPTUM, INC. (UNITEDHEALTH GROUP)
      • 12.1.3.1 Business overview
      • 12.1.3.2 Products & services offered
      • 12.1.3.3 Recent developments
        • 12.1.3.3.1 Product launches & enhancements
        • 12.1.3.3.2 Deals
      • 12.1.3.4 MnM view
        • 12.1.3.4.1 Right to win
        • 12.1.3.4.2 Strategic choices
        • 12.1.3.4.3 Weaknesses & competitive threats
    • 12.1.4 INTELEX TECHNOLOGIES (FORTIVE)
      • 12.1.4.1 Business overview
      • 12.1.4.2 Products & services offered
      • 12.1.4.3 Recent developments
        • 12.1.4.3.1 Product launches & enhancements
        • 12.1.4.3.2 Expansions
      • 12.1.4.4 MnM view
        • 12.1.4.4.1 Right to win
        • 12.1.4.4.2 Strategic choices
        • 12.1.4.4.3 Weaknesses & competitive threats
    • 12.1.5 DNV
      • 12.1.5.1 Business overview
      • 12.1.5.2 Products & services offered
      • 12.1.5.3 Recent developments
        • 12.1.5.3.1 Product launches
        • 12.1.5.3.2 Deals
      • 12.1.5.4 MnM view
        • 12.1.5.4.1 Right to win
        • 12.1.5.4.2 Strategic choices
        • 12.1.5.4.3 Weaknesses & competitive threats
    • 12.1.6 RLDATIX
      • 12.1.6.1 Business overview
      • 12.1.6.2 Products & services offered
      • 12.1.6.3 Recent developments
        • 12.1.6.3.1 Product launches & enhancements
        • 12.1.6.3.2 Deals
        • 12.1.6.3.3 Other developments
      • 12.1.6.4 MnM view
        • 12.1.6.4.1 Right to win
        • 12.1.6.4.2 Strategic choices
        • 12.1.6.4.3 Weaknesses & competitive threats
    • 12.1.7 RISKONNECT, INC.
      • 12.1.7.1 Business overview
      • 12.1.7.2 Products & services offered
      • 12.1.7.3 Recent developments
        • 12.1.7.3.1 Product enhancements
        • 12.1.7.3.2 Deals
    • 12.1.8 HCI
      • 12.1.8.1 Business overview
      • 12.1.8.2 Products & services offered
      • 12.1.8.3 Recent developments
        • 12.1.8.3.1 Product launches
        • 12.1.8.3.2 Other developments
    • 12.1.9 IDEAGEN
      • 12.1.9.1 Business overview
      • 12.1.9.2 Products & services offered
      • 12.1.9.3 Recent developments
        • 12.1.9.3.1 Product launches
        • 12.1.9.3.2 Deals
    • 12.1.10 MEDISOLV, INC.
      • 12.1.10.1 Business overview
      • 12.1.10.2 Products & services offered
      • 12.1.10.3 Recent developments
        • 12.1.10.3.1 Product approvals & enhancements
        • 12.1.10.3.2 Deals
    • 12.1.11 VALENZ HEALTH
      • 12.1.11.1 Business overview
      • 12.1.11.2 Products & services offered
      • 12.1.11.3 Recent developments
        • 12.1.11.3.1 Product launches
        • 12.1.11.3.2 Deals
    • 12.1.12 ODITEK SOLUTIONS
      • 12.1.12.1 Business overview
      • 12.1.12.2 Products & services offered
    • 12.1.13 THE PATIENT SAFETY COMPANY (TPSC)
      • 12.1.13.1 Business overview
      • 12.1.13.2 Products & services offered
      • 12.1.13.3 Recent developments
        • 12.1.13.3.1 Product enhancements
    • 12.1.14 MORCARE
      • 12.1.14.1 Business overview
      • 12.1.14.2 Products & services offered
    • 12.1.15 YOUCOMPLY, LTD. (VICLARITY)
      • 12.1.15.1 Business overview
      • 12.1.15.2 Products & services offered
      • 12.1.15.3 Recent developments
        • 12.1.15.3.1 Product launches & enhancements
    • 12.1.16 SIMPLERQMS
      • 12.1.16.1 Business overview
      • 12.1.16.2 Products & services offered
    • 12.1.17 NAVEX GLOBAL, INC. (GOLDMAN SACHS)
      • 12.1.17.1 Business overview
      • 12.1.17.2 Products & services offered
      • 12.1.17.3 Recent developments
        • 12.1.17.3.1 Product enhancements
        • 12.1.17.3.2 Deals
    • 12.1.18 PROVIDERTRUST
      • 12.1.18.1 Business overview
      • 12.1.18.2 Products & services offered
      • 12.1.18.3 Recent developments
        • 12.1.18.3.1 Product launches
        • 12.1.18.3.2 Deals
    • 12.1.19 MEDTRAINER
      • 12.1.19.1 Business overview
      • 12.1.19.2 Products & services offered
      • 12.1.19.3 Recent developments
        • 12.1.19.3.1 Product launches
        • 12.1.19.3.2 Deals
        • 12.1.19.3.3 Other developments
  • 12.2 OTHER PLAYERS
    • 12.2.1 OKKALA SOLUTIONS PRIVATE LIMITED
    • 12.2.2 SAFEQUAL
    • 12.2.3 EFFIVITY TECHNOLOGIES, INC.
    • 12.2.4 TITLE21 HEALTH SOLUTIONS
    • 12.2.5 MEDBLAZE (INFINI)
    • 12.2.6 ETASKPRO
    • 12.2.7 QUALITYZE
    • 12.2.8 KARMINN CONSULTANCY NETWORK
    • 12.2.9 MEG

13 APPENDIX

  • 13.1 DISCUSSION GUIDE
  • 13.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 13.3 CUSTOMIZATION OPTIONS
  • 13.4 RELATED REPORTS
  • 13.5 AUTHOR DETAILS

List of Tables

  • TABLE 1 RISK ASSESSMENT: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET
  • TABLE 2 HEALTHCARE QUALITY MANAGEMENT (QMS): IMPACT ANALYSIS OF MARKET DYNAMICS
  • TABLE 3 US: INTEROPERABILITY FREQUENCY AMONG NON-FEDERAL ACUTE CARE HOSPITALS, BY HOSPITAL CHARACTERISTIC (2023)
  • TABLE 4 QMS REQUIREMENTS
  • TABLE 5 INDICATIVE PRICING OF HEALTHCARE QUALITY MANAGEMENT (QMS) SOLUTIONS, BY KEY PLAYER (2024)
  • TABLE 6 INDICATIVE PRICING OF HEALTHCARE QUALITY MANAGEMENT (QMS) SOLUTIONS, BY REGION (2024)
  • TABLE 7 HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET: ROLE OF COMPANIES IN ECOSYSTEM
  • TABLE 8 JURISDICTION ANALYSIS OF TOP APPLICANT COUNTRIES FOR HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET (2025)
  • TABLE 9 HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET: DETAILED LIST OF MAJOR CONFERENCES & EVENTS, 2025-2026
  • TABLE 10 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 11 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 12 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 13 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 14 MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 15 REGULATORY SCENARIO OF NORTH AMERICA
  • TABLE 16 REGULATORY SCENARIO OF EUROPE
  • TABLE 17 REGULATORY SCENARIO OF ASIA PACIFIC
  • TABLE 18 REGULATORY SCENARIO OF MIDDLE EAST & AFRICA
  • TABLE 19 REGULATORY SCENARIO OF LATIN AMERICA
  • TABLE 20 HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET: PORTER'S FIVE FORCES ANALYSIS
  • TABLE 21 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY END USER (%)
  • TABLE 22 KEY BUYING CRITERIA FOR END USERS
  • TABLE 23 UNMET NEEDS IN HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET
  • TABLE 24 END-USER EXPECTATIONS IN HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET
  • TABLE 25 US-ADJUSTED RECIPROCAL TARIFF RATES
  • TABLE 26 HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY OFFERING, 2023-2030 (USD MILLION)
  • TABLE 27 HEALTHCARE QUALITY MANAGEMENT (QMS) SOFTWARE MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 28 HEALTHCARE QUALITY MANAGEMENT (QMS) SOFTWARE MARKET, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 29 INTEGRATED SUITES OFFERED BY MAJOR PLAYERS
  • TABLE 30 HEALTHCARE QUALITY MANAGEMENT (QMS) SOFTWARE MARKET FOR INTEGRATED SUITES, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 31 POINT SOLUTIONS OFFERED BY MAJOR PLAYERS
  • TABLE 32 HEALTHCARE QUALITY MANAGEMENT (QMS) SOFTWARE MARKET FOR BY POINT SOLUTIONS, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 33 HEALTHCARE QUALITY MANAGEMENT (QMS) SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 34 HEALTHCARE QUALITY MANAGEMENT (QMS) SERVICES MARKET, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 35 HEALTHCARE QUALITY MANAGEMENT (QMS) SERVICES MARKET FOR IMPLEMENTATION & TRAINING SERVICES, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 36 HEALTHCARE QUALITY MANAGEMENT (QMS) SERVICES MARKET FOR SUPPORT SERVICES, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 37 HEALTHCARE QUALITY MANAGEMENT (QMS) SERVICES MARKET FOR CONSULTING SERVICES, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 38 HEALTHCARE QUALITY MANAGEMENT (QMS) SERVICES MARKET FOR OTHER SERVICES, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 39 HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY FUNCTION, 2023-2030 (USD MILLION)
  • TABLE 40 HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET FOR DOCUMENT MANAGEMENT, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 41 HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET FOR RISK MANAGEMENT, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 42 HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET FOR AUDIT MANAGEMENT, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 43 HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET FOR CAPA & NONCONFORMANCE MANAGEMENT, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 44 HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET FOR CHANGE MANAGEMENT, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 45 HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET FOR COMPLAINT MANAGEMENT, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 46 HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET FOR TRAINING MANAGEMENT, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 47 HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET FOR OTHER FUNCTIONS, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 48 HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY USE CASE, 2023-2030 (USD MILLION)
  • TABLE 49 HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET FOR PHYSICIAN QUALITY REPORTING, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 50 BUSINESS INTELLIGENCE & ANALYTICS SOLUTIONS OFFERED BY MAJOR PLAYERS
  • TABLE 51 HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET FOR BUSINESS INTELLIGENCE & ANALYTICS, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 52 HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET FOR CLINICAL RISK MANAGEMENT, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 53 PROVIDER PERFORMANCE MANAGEMENT SOLUTIONS OFFERED BY MAJOR PLAYERS
  • TABLE 54 HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET FOR PROVIDER PERFORMANCE MANAGEMENT, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 55 HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET FOR REGULATORY & ACCREDITATION COMPLIANCE, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 56 HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET FOR PATIENT EXPERIENCE & ENGAGEMENT, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 57 HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 58 HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 59 HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET FOR HEALTHCARE PROVIDERS, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 60 HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET FOR HOSPITALS, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 61 HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET FOR OUTPATIENT & AMBULATORY CARE CENTERS, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 62 HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET FOR PHYSICIAN & GROUP PRACTICES, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 63 HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET FOR LONG-TERM CARE & POST-ACUTE FACILITIES, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 64 HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET FOR OTHER HEALTHCARE PROVIDERS, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 65 HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET FOR HEALTHCARE PAYERS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 66 HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET FOR HEALTHCARE PAYERS, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 67 HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET FOR PUBLIC PAYERS, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 68 HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET FOR PRIVATE PAYERS, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 69 HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 70 NORTH AMERICA: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 71 NORTH AMERICA: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY OFFERING, 2023-2030 (USD MILLION)
  • TABLE 72 NORTH AMERICA: HEALTHCARE QUALITY MANAGEMENT (QMS) SOFTWARE MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 73 NORTH AMERICA: HEALTHCARE QUALITY MANAGEMENT (QMS) SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 74 NORTH AMERICA: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY FUNCTION, 2023-2030 (USD MILLION)
  • TABLE 75 NORTH AMERICA: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY USE CASE, 2023-2030 (USD MILLION)
  • TABLE 76 NORTH AMERICA: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 77 NORTH AMERICA: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 78 NORTH AMERICA: HEALTHCARE QUALITY MANAGEMENT (QMS) FOR HEALTHCARE PAYERS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 79 US: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY OFFERING, 2023-2030 (USD MILLION)
  • TABLE 80 US: HEALTHCARE QUALITY MANAGEMENT (QMS) SOFTWARE MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 81 US: HEALTHCARE QUALITY MANAGEMENT (QMS) SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 82 US: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY FUNCTION, 2023-2030 (USD MILLION)
  • TABLE 83 US: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY USE CASE, 2023-2030 (USD MILLION)
  • TABLE 84 US: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 85 US: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 86 US: HEALTHCARE QUALITY MANAGEMENT (QMS) FOR HEALTHCARE PAYERS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 87 CANADA: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY OFFERING, 2023-2030 (USD MILLION)
  • TABLE 88 CANADA: HEALTHCARE QUALITY MANAGEMENT (QMS) SOFTWARE MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 89 CANADA: HEALTHCARE QUALITY MANAGEMENT (QMS) SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 90 CANADA: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY FUNCTION, 2023-2030 (USD MILLION)
  • TABLE 91 CANADA: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY USE CASE, 2023-2030 (USD MILLION)
  • TABLE 92 CANADA: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 93 CANADA: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 94 CANADA: HEALTHCARE QUALITY MANAGEMENT (QMS) FOR HEALTHCARE PAYERS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 95 EUROPE: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 96 EUROPE: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY OFFERING, 2023-2030 (USD MILLION)
  • TABLE 97 EUROPE: HEALTHCARE QUALITY MANAGEMENT (QMS) SOFTWARE MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 98 EUROPE: HEALTHCARE QUALITY MANAGEMENT (QMS) SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 99 EUROPE: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY FUNCTION, 2023-2030 (USD MILLION)
  • TABLE 100 EUROPE: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY USE CASE, 2023-2030 (USD MILLION)
  • TABLE 101 EUROPE: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 102 EUROPE: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 103 EUROPE: HEALTHCARE QUALITY MANAGEMENT (QMS) FOR HEALTHCARE PAYERS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 104 UK: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY OFFERING, 2023-2030 (USD MILLION)
  • TABLE 105 UK: HEALTHCARE QUALITY MANAGEMENT (QMS) SOFTWARE MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 106 UK: HEALTHCARE QUALITY MANAGEMENT (QMS) SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 107 UK: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY FUNCTION, 2023-2030 (USD MILLION)
  • TABLE 108 UK: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY USE CASE, 2023-2030 (USD MILLION)
  • TABLE 109 UK: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 110 UK: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 111 UK: HEALTHCARE QUALITY MANAGEMENT (QMS) FOR HEALTHCARE PAYERS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 112 GERMANY: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY OFFERING, 2023-2030 (USD MILLION)
  • TABLE 113 GERMANY: HEALTHCARE QUALITY MANAGEMENT (QMS) SOFTWARE MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 114 GERMANY: HEALTHCARE QUALITY MANAGEMENT (QMS) SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 115 GERMANY: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY FUNCTION, 2023-2030 (USD MILLION)
  • TABLE 116 GERMANY: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY USE CASE, 2023-2030 (USD MILLION)
  • TABLE 117 GERMANY: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 118 GERMANY: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 119 GERMANY: HEALTHCARE QUALITY MANAGEMENT (QMS) FOR HEALTHCARE PAYERS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 120 FRANCE: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY OFFERING, 2023-2030 (USD MILLION)
  • TABLE 121 FRANCE: HEALTHCARE QUALITY MANAGEMENT (QMS) SOFTWARE MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 122 FRANCE: HEALTHCARE QUALITY MANAGEMENT (QMS) SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 123 FRANCE: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY FUNCTION, 2023-2030 (USD MILLION)
  • TABLE 124 FRANCE: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY USE CASE, 2023-2030 (USD MILLION)
  • TABLE 125 FRANCE: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 126 FRANCE: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 127 FRANCE: HEALTHCARE QUALITY MANAGEMENT (QMS) FOR HEALTHCARE PAYERS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 128 ITALY: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY OFFERING, 2023-2030 (USD MILLION)
  • TABLE 129 ITALY: HEALTHCARE QUALITY MANAGEMENT (QMS) SOFTWARE MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 130 ITALY: HEALTHCARE QUALITY MANAGEMENT (QMS) SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 131 ITALY: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY FUNCTION, 2023-2030 (USD MILLION)
  • TABLE 132 ITALY: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY USE CASE, 2023-2030 (USD MILLION)
  • TABLE 133 ITALY: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 134 ITALY: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 135 ITALY: HEALTHCARE QUALITY MANAGEMENT (QMS) FOR HEALTHCARE PAYERS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 136 SPAIN: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY OFFERING, 2023-2030 (USD MILLION)
  • TABLE 137 SPAIN: HEALTHCARE QUALITY MANAGEMENT (QMS) SOFTWARE MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 138 SPAIN: HEALTHCARE QUALITY MANAGEMENT (QMS) SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 139 SPAIN: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY FUNCTION, 2023-2030 (USD MILLION)
  • TABLE 140 SPAIN: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY USE CASE, 2023-2030 (USD MILLION)
  • TABLE 141 SPAIN: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 142 SPAIN: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 143 SPAIN: HEALTHCARE QUALITY MANAGEMENT (QMS) FOR HEALTHCARE PAYERS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 144 REST OF EUROPE: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY OFFERING, 2023-2030 (USD MILLION)
  • TABLE 145 REST OF EUROPE: HEALTHCARE QUALITY MANAGEMENT (QMS) SOFTWARE MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 146 REST OF EUROPE: HEALTHCARE QUALITY MANAGEMENT (QMS) SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 147 REST OF EUROPE: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY FUNCTION, 2023-2030 (USD MILLION)
  • TABLE 148 REST OF EUROPE: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY USE CASE, 2023-2030 (USD MILLION)
  • TABLE 149 REST OF EUROPE: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 150 REST OF EUROPE: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 151 REST OF EUROPE: HEALTHCARE QUALITY MANAGEMENT (QMS) FOR HEALTHCARE PAYERS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 152 ASIA PACIFIC: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 153 ASIA PACIFIC: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY OFFERING, 2023-2030 (USD MILLION)
  • TABLE 154 ASIA PACIFIC: HEALTHCARE QUALITY MANAGEMENT (QMS) SOFTWARE MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 155 ASIA PACIFIC: HEALTHCARE QUALITY MANAGEMENT (QMS) SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 156 ASIA PACIFIC: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY FUNCTION, 2023-2030 (USD MILLION)
  • TABLE 157 ASIA PACIFIC: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY USE CASE, 2023-2030 (USD MILLION)
  • TABLE 158 ASIA PACIFIC: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 159 ASIA PACIFIC: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 160 ASIA PACIFIC: HEALTHCARE QUALITY MANAGEMENT (QMS) FOR HEALTHCARE PAYERS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 161 JAPAN: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY OFFERING, 2023-2030 (USD MILLION)
  • TABLE 162 JAPAN: HEALTHCARE QUALITY MANAGEMENT (QMS) SOFTWARE MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 163 JAPAN: HEALTHCARE QUALITY MANAGEMENT (QMS) SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 164 JAPAN: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY FUNCTION, 2023-2030 (USD MILLION)
  • TABLE 165 JAPAN: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY USE CASE, 2023-2030 (USD MILLION)
  • TABLE 166 JAPAN: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 167 JAPAN: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 168 JAPAN: HEALTHCARE QUALITY MANAGEMENT (QMS) FOR HEALTHCARE PAYERS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 169 CHINA: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY OFFERING, 2023-2030 (USD MILLION)
  • TABLE 170 CHINA: HEALTHCARE QUALITY MANAGEMENT (QMS) SOFTWARE MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 171 CHINA: HEALTHCARE QUALITY MANAGEMENT (QMS) SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 172 CHINA: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY FUNCTION, 2023-2030 (USD MILLION)
  • TABLE 173 CHINA: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY USE CASE, 2023-2030 (USD MILLION)
  • TABLE 174 CHINA: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 175 CHINA: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 176 CHINA: HEALTHCARE QUALITY MANAGEMENT (QMS) FOR HEALTHCARE PAYERS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 177 INDIA: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY OFFERING, 2023-2030 (USD MILLION)
  • TABLE 178 INDIA: HEALTHCARE QUALITY MANAGEMENT (QMS) SOFTWARE MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 179 INDIA: HEALTHCARE QUALITY MANAGEMENT (QMS) SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 180 INDIA: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY FUNCTION, 2023-2030 (USD MILLION)
  • TABLE 181 INDIA: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY USE CASE, 2023-2030 (USD MILLION)
  • TABLE 182 INDIA: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 183 INDIA: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 184 INDIA: HEALTHCARE QUALITY MANAGEMENT (QMS) FOR HEALTHCARE PAYERS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 185 SOUTH KOREA: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY OFFERING, 2023-2030 (USD MILLION)
  • TABLE 186 SOUTH KOREA: HEALTHCARE QUALITY MANAGEMENT (QMS) SOFTWARE MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 187 SOUTH KOREA: HEALTHCARE QUALITY MANAGEMENT (QMS) SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 188 SOUTH KOREA: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY FUNCTION, 2023-2030 (USD MILLION)
  • TABLE 189 SOUTH KOREA: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY USE CASE, 2023-2030 (USD MILLION)
  • TABLE 190 SOUTH KOREA: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 191 SOUTH KOREA: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 192 SOUTH KOREA: HEALTHCARE QUALITY MANAGEMENT (QMS) FOR HEALTHCARE PAYERS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 193 AUSTRALIA: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY OFFERING, 2023-2030 (USD MILLION)
  • TABLE 194 AUSTRALIA: HEALTHCARE QUALITY MANAGEMENT (QMS) SOFTWARE MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 195 AUSTRALIA: HEALTHCARE QUALITY MANAGEMENT (QMS) SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 196 AUSTRALIA: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY FUNCTION, 2023-2030 (USD MILLION)
  • TABLE 197 AUSTRALIA: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY USE CASE, 2023-2030 (USD MILLION)
  • TABLE 198 AUSTRALIA: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 199 AUSTRALIA: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 200 AUSTRALIA: HEALTHCARE QUALITY MANAGEMENT (QMS) FOR HEALTHCARE PAYERS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 201 REST OF ASIA PACIFIC: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY OFFERING, 2023-2030 (USD MILLION)
  • TABLE 202 REST OF ASIA PACIFIC: HEALTHCARE QUALITY MANAGEMENT (QMS) SOFTWARE MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 203 REST OF ASIA PACIFIC: HEALTHCARE QUALITY MANAGEMENT (QMS) SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 204 REST OF ASIA PACIFIC: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY FUNCTION, 2023-2030 (USD MILLION)
  • TABLE 205 REST OF ASIA PACIFIC: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY USE CASE, 2023-2030 (USD MILLION)
  • TABLE 206 REST OF ASIA PACIFIC: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 207 REST OF ASIA PACIFIC: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 208 REST OF ASIA PACIFIC: HEALTHCARE QUALITY MANAGEMENT (QMS) FOR HEALTHCARE PAYERS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 209 LATIN AMERICA: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 210 LATIN AMERICA: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY OFFERING, 2023-2030 (USD MILLION)
  • TABLE 211 LATIN AMERICA: HEALTHCARE QUALITY MANAGEMENT (QMS) SOFTWARE MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 212 LATIN AMERICA: HEALTHCARE QUALITY MANAGEMENT (QMS) SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 213 LATIN AMERICA: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY FUNCTION, 2023-2030 (USD MILLION)
  • TABLE 214 LATIN AMERICA: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY USE CASE, 2023-2030 (USD MILLION)
  • TABLE 215 LATIN AMERICA: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 216 LATIN AMERICA: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 217 LATIN AMERICA: HEALTHCARE QUALITY MANAGEMENT (QMS) FOR HEALTHCARE PAYERS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 218 BRAZIL: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY OFFERING, 2023-2030 (USD MILLION)
  • TABLE 219 BRAZIL: HEALTHCARE QUALITY MANAGEMENT (QMS) SOFTWARE MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 220 BRAZIL: HEALTHCARE QUALITY MANAGEMENT (QMS) SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 221 BRAZIL: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY FUNCTION, 2023-2030 (USD MILLION)
  • TABLE 222 BRAZIL: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY USE CASE, 2023-2030 (USD MILLION)
  • TABLE 223 BRAZIL: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 224 BRAZIL: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 225 BRAZIL: HEALTHCARE QUALITY MANAGEMENT (QMS) FOR HEALTHCARE PAYERS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 226 MEXICO: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY OFFERING, 2023-2030 (USD MILLION)
  • TABLE 227 MEXICO: HEALTHCARE QUALITY MANAGEMENT (QMS) SOFTWARE MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 228 MEXICO: HEALTHCARE QUALITY MANAGEMENT (QMS) SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 229 MEXICO: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY FUNCTION, 2023-2030 (USD MILLION)
  • TABLE 230 MEXICO: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY USE CASE, 2023-2030 (USD MILLION)
  • TABLE 231 MEXICO: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 232 MEXICO: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 233 MEXICO: HEALTHCARE QUALITY MANAGEMENT (QMS) FOR HEALTHCARE PAYERS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 234 REST OF LATIN AMERICA: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY OFFERING, 2023-2030 (USD MILLION)
  • TABLE 235 REST OF LATIN AMERICA: HEALTHCARE QUALITY MANAGEMENT (QMS) SOFTWARE MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 236 REST OF LATIN AMERICA: HEALTHCARE QUALITY MANAGEMENT (QMS) SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 237 REST OF LATIN AMERICA: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY FUNCTION, 2023-2030 (USD MILLION)
  • TABLE 238 REST OF LATIN AMERICA: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY USE CASE, 2023-2030 (USD MILLION)
  • TABLE 239 REST OF LATIN AMERICA: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 240 REST OF LATIN AMERICA: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 241 REST OF LATIN AMERICA: HEALTHCARE QUALITY MANAGEMENT (QMS) FOR HEALTHCARE PAYERS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 242 MIDDLE EAST & AFRICA: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 243 MIDDLE EAST & AFRICA: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY OFFERING, 2023-2030 (USD MILLION)
  • TABLE 244 MIDDLE EAST & AFRICA: HEALTHCARE QUALITY MANAGEMENT (QMS) SOFTWARE MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 245 MIDDLE EAST & AFRICA: HEALTHCARE QUALITY MANAGEMENT (QMS) SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 246 MIDDLE EAST & AFRICA: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY FUNCTION, 2023-2030 (USD MILLION)
  • TABLE 247 MIDDLE EAST & AFRICA: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY USE CASE, 2023-2030 (USD MILLION)
  • TABLE 248 MIDDLE EAST & AFRICA: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 249 MIDDLE EAST & AFRICA: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 250 MIDDLE EAST & AFRICA: HEALTHCARE QUALITY MANAGEMENT (QMS) FOR HEALTHCARE PAYERS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 251 GCC COUNTRIES: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 252 GCC COUNTRIES: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY OFFERING, 2023-2030 (USD MILLION)
  • TABLE 253 GCC COUNTRIES: HEALTHCARE QUALITY MANAGEMENT (QMS) SOFTWARE MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 254 GCC COUNTRIES: HEALTHCARE QUALITY MANAGEMENT (QMS) SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 255 GCC COUNTRIES: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY FUNCTION, 2023-2030 (USD MILLION)
  • TABLE 256 GCC COUNTRIES: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY USE CASE, 2023-2030 (USD MILLION)
  • TABLE 257 GCC COUNTRIES: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 258 GCC COUNTRIES: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 259 GCC COUNTRIES: HEALTHCARE QUALITY MANAGEMENT (QMS) FOR HEALTHCARE PAYERS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 260 SAUDI ARABIA: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY OFFERING, 2023-2030 (USD MILLION)
  • TABLE 261 SAUDI ARABIA: HEALTHCARE QUALITY MANAGEMENT (QMS) SOFTWARE MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 262 SAUDI ARABIA: HEALTHCARE QUALITY MANAGEMENT (QMS) SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 263 SAUDI ARABIA: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY FUNCTION, 2023-2030 (USD MILLION)
  • TABLE 264 SAUDI ARABIA: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY USE CASE, 2023-2030 (USD MILLION)
  • TABLE 265 SAUDI ARABIA: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 266 SAUDI ARABIA: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 267 SAUDI ARABIA: HEALTHCARE QUALITY MANAGEMENT (QMS) FOR HEALTHCARE PAYERS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 268 UAE: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY OFFERING, 2023-2030 (USD MILLION)
  • TABLE 269 UAE: HEALTHCARE QUALITY MANAGEMENT (QMS) SOFTWARE MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 270 UAE: HEALTHCARE QUALITY MANAGEMENT (QMS) SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 271 UAE: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY FUNCTION, 2023-2030 (USD MILLION)
  • TABLE 272 UAE: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY USE CASE, 2023-2030 (USD MILLION)
  • TABLE 273 UAE: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 274 UAE: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 275 UAE: HEALTHCARE QUALITY MANAGEMENT (QMS) FOR HEALTHCARE PAYERS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 276 REST OF GCC COUNTRIES: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY OFFERING, 2023-2030 (USD MILLION)
  • TABLE 277 REST OF GCC COUNTRIES: HEALTHCARE QUALITY MANAGEMENT (QMS) SOFTWARE MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 278 REST OF GCC COUNTRIES: HEALTHCARE QUALITY MANAGEMENT (QMS) SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 279 REST OF GCC COUNTRIES: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY FUNCTION, 2023-2030 (USD MILLION)
  • TABLE 280 REST OF GCC COUNTRIES: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY USE CASE, 2023-2030 (USD MILLION)
  • TABLE 281 REST OF GCC COUNTRIES: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 282 REST OF GCC COUNTRIES: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 283 REST OF GCC COUNTRIES: HEALTHCARE QUALITY MANAGEMENT (QMS) FOR HEALTHCARE PAYERS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 284 REST OF MIDDLE EAST & AFRICA: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY OFFERING, 2023-2030 (USD MILLION)
  • TABLE 285 REST OF MIDDLE EAST & AFRICA: HEALTHCARE QUALITY MANAGEMENT (QMS) SOFTWARE MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 286 REST OF MIDDLE EAST & AFRICA: HEALTHCARE QUALITY MANAGEMENT (QMS) SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 287 REST OF MIDDLE EAST & AFRICA: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY FUNCTION, 2023-2030 (USD MILLION)
  • TABLE 288 REST OF MIDDLE EAST & AFRICA: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY USE CASE, 2023-2030 (USD MILLION)
  • TABLE 289 REST OF MIDDLE EAST & AFRICA: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 290 REST OF MIDDLE EAST & AFRICA: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 291 REST OF MIDDLE EAST & AFRICA: HEALTHCARE QUALITY MANAGEMENT (QMS) FOR HEALTHCARE PAYERS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 292 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN HEALTHCARE QUALITY MANAGEMENT (QMS), JANUARY 2022-SEPTEMBER 2025
  • TABLE 293 HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET: DEGREE OF COMPETITION
  • TABLE 294 HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET: REGION FOOTPRINT
  • TABLE 295 HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET: OFFERING FOOTPRINT
  • TABLE 296 HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET: FUNCTION FOOTPRINT
  • TABLE 297 HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET: USE CASE FOOTPRINT
  • TABLE 298 HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET: END-USER FOOTPRINT
  • TABLE 299 HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET: DETAILED LIST OF KEY STARTUP/SME PLAYERS
  • TABLE 300 HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET: COMPETITIVE BENCHMARKING OF KEY EMERGING PLAYERS/STARTUPS, BY REGION
  • TABLE 301 HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET: COMPETITIVE BENCHMARKING OF KEY EMERGING PLAYERS/STARTUPS, BY FUNCTION
  • TABLE 302 HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET: PRODUCT LAUNCHES & ENHANCEMENTS, JANUARY 2022-SEPTEMBER 2025
  • TABLE 303 HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET: DEALS, JANUARY 2022-SEPTEMBER 2025
  • TABLE 304 HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET: OTHER DEVELOPMENTS, JANUARY 2022-SEPTEMBER 2025
  • TABLE 305 NUANCE COMMUNICATIONS, INC. (MICROSOFT): COMPANY OVERVIEW
  • TABLE 306 NUANCE COMMUNICATIONS, INC. (MICROSOFT): PRODUCTS & SERVICES OFFERED
  • TABLE 307 NUANCE COMMUNICATIONS, INC. (MICROSOFT): DEALS, JANUARY 2022-SEPTEMBER 2025
  • TABLE 308 PREMIER INC.: COMPANY OVERVIEW
  • TABLE 309 PREMIER INC.: PRODUCTS & SERVICES OFFERED
  • TABLE 310 PREMIER INC.: PRODUCT ENHANCEMENTS, JANUARY 2022-SEPTEMBER 2025
  • TABLE 311 PREMIER INC.: DEALS, JANUARY 2022-SEPTEMBER 2025
  • TABLE 312 OPTUM, INC. (UNITEDHEALTH GROUP): COMPANY OVERVIEW
  • TABLE 313 OPTUM, INC. (UNITEDHEALTH GROUP): PRODUCTS & SERVICES OFFERED
  • TABLE 314 OPTUM, INC. (UNITEDHEALTH GROUP): PRODUCT LAUNCHES & ENHANCEMENTS, ENHANCEMENT, JANUARY 2022-SEPTEMBER 2025
  • TABLE 315 OPTUM, INC. (UNITEDHEALTH GROUP): DEALS, JANUARY 2022-SEPTEMBER 2025
  • TABLE 316 INTELEX TECHNOLOGIES (FORTIVE): COMPANY OVERVIEW
  • TABLE 317 INTELEX TECHNOLOGIES (FORTIVE): PRODUCTS & SERVICES OFFERED
  • TABLE 318 INTELEX TECHNOLOGIES (FORTIVE): PRODUCT LAUNCHES & ENHANCEMENTS, JANUARY 2022-SEPTEMBER 2025
  • TABLE 319 INTELEX TECHNOLOGIES (FORTIVE): EXPANSIONS, JANUARY 2022-SEPTEMBER 2025
  • TABLE 320 DNV: COMPANY OVERVIEW
  • TABLE 321 DNV: PRODUCTS & SERVICES OFFERED
  • TABLE 322 DNV: PRODUCT LAUNCHES, JANUARY 2022-SEPTEMBER 2025
  • TABLE 323 DNV: DEALS, JANUARY 2022-SEPTEMBER 2025
  • TABLE 324 RLDATIX: COMPANY OVERVIEW
  • TABLE 325 RLDATIX: PRODUCTS & SERVICES OFFERED
  • TABLE 326 RLDATIX: PRODUCT LAUNCHES & ENHANCEMENTS, JANUARY 2022-SEPTEMBER 2025
  • TABLE 327 RLDATIX: DEALS, JANUARY 2022-SEPTEMBER 2025
  • TABLE 328 RLDATIX: OTHER DEVELOPMENTS, JANUARY 2022-SEPTEMBER 2025
  • TABLE 329 RISKONNECT, INC.: COMPANY OVERVIEW
  • TABLE 330 RISKONNECT, INC.: PRODUCTS & SERVICES OFFERED
  • TABLE 331 RISKONNECT, INC.: PRODUCT ENHANCEMENTS, JANUARY 2022-SEPTEMBER 2025
  • TABLE 332 RISKONNECT, INC.: DEALS, JANUARY 2022-SEPTEMBER 2025
  • TABLE 333 HCI: COMPANY OVERVIEW
  • TABLE 334 HCI: PRODUCTS & SERVICES OFFERED
  • TABLE 335 HCI: PRODUCT LAUNCHES, JANUARY 2022-SEPTEMBER 2025
  • TABLE 336 HCI: OTHER DEVELOPMENTS, JANUARY 2022-SEPTEMBER 2025
  • TABLE 337 IDEAGEN: COMPANY OVERVIEW
  • TABLE 338 IDEAGEN: PRODUCTS & SERVICES OFFERED
  • TABLE 339 IDEAGEN: PRODUCT LAUNCHES, JANUARY 2022-SEPTEMBER 2025
  • TABLE 340 IDEAGEN: DEALS, JANUARY 2022-SEPTEMBER 2025
  • TABLE 341 MEDISOLV, INC.: COMPANY OVERVIEW
  • TABLE 342 MEDISOLV, INC.: PRODUCTS & SERVICES OFFERED
  • TABLE 343 MEDISOLV, INC.: PRODUCT APPROVALS & ENHANCEMENTS, JANUARY 2022-SEPTEMBER 2025
  • TABLE 344 MEDISOLV, INC.: DEALS, JANUARY 2022-SEPTEMBER 2025
  • TABLE 345 VALENZ HEALTH: COMPANY OVERVIEW
  • TABLE 346 VALENZ HEALTH: PRODUCTS & SERVICES OFFERED
  • TABLE 347 VALENZ HEALTH: PRODUCT LAUNCHES, JANUARY 2022-SEPTEMBER 2025
  • TABLE 348 VALENZ HEALTH: DEALS, JANUARY 2022-SEPTEMBER 2025
  • TABLE 349 ODITEK SOLUTIONS: COMPANY OVERVIEW
  • TABLE 350 ODITEK SOLUTIONS: PRODUCTS & SERVICES OFFERED
  • TABLE 351 THE PATIENT SAFETY COMPANY (TPSC): COMPANY OVERVIEW
  • TABLE 352 THE PATIENT SAFETY COMPANY (TPSC): PRODUCTS & SERVICES OFFERED
  • TABLE 353 THE PATIENT SAFETY COMPANY (TPSC): PRODUCT ENHANCEMENTS, JANUARY 2022-SEPTEMBER 2025
  • TABLE 354 MORCARE: COMPANY OVERVIEW
  • TABLE 355 MORCARE: PRODUCTS & SERVICES OFFERED
  • TABLE 356 YOUCOMPLY, LTD. (VICLARITY): COMPANY OVERVIEW
  • TABLE 357 YOUCOMPLY, LTD. (VICLARITY): PRODUCTS & SERVICES OFFERED
  • TABLE 358 YOUCOMPLY, LTD. (VICLARITY): PRODUCT LAUNCHES & ENHANCEMENTS, JANUARY 2022-SEPTEMBER 2025
  • TABLE 359 SIMPLERQMS: COMPANY OVERVIEW
  • TABLE 360 SIMPLERQMS: PRODUCTS & SERVICES OFFERED
  • TABLE 361 NAVEX GLOBAL, INC. (GOLDMAN SACHS): COMPANY OVERVIEW
  • TABLE 362 NAVEX GLOBAL, INC. (GOLDMAN SACHS): PRODUCTS & SERVICES OFFERED
  • TABLE 363 NAVEX GLOBAL, INC. (GOLDMAN SACHS): PRODUCT ENHANCEMENTS, JANUARY 2022-SEPTEMBER 2025
  • TABLE 364 NAVEX GLOBAL, INC. (GOLDMAN SACHS): DEALS, JANUARY 2022-SEPTEMBER 2025
  • TABLE 365 PROVIDERTRUST: COMPANY OVERVIEW
  • TABLE 366 PROVIDERTRUST: PRODUCTS & SERVICES OFFERED
  • TABLE 367 PROVIDERTRUST: PRODUCT LAUNCHES, JANUARY 2022-SEPTEMBER 2025
  • TABLE 368 PROVIDERTRUST: DEALS, JANUARY 2022-SEPTEMBER 2025
  • TABLE 369 MEDTRAINER: COMPANY OVERVIEW
  • TABLE 370 MEDTRAINER: PRODUCTS & SERVICES OFFERED
  • TABLE 371 MEDTRAINER: PRODUCT LAUNCHES, JANUARY 2022-SEPTEMBER 2025
  • TABLE 372 MEDTRAINER: DEALS, JANUARY 2022-SEPTEMBER 2025
  • TABLE 373 MEDTRAINER: OTHER DEVELOPMENTS, JANUARY 2021-SEPTEMBER 2025
  • TABLE 374 OKKALA SOLUTIONS PRIVATE LIMITED: COMPANY OVERVIEW
  • TABLE 375 SAFEQUAL: COMPANY OVERVIEW
  • TABLE 376 EFFIVITY TECHNOLOGIES, INC.: COMPANY OVERVIEW
  • TABLE 377 TITLE21 HEALTH SOLUTIONS: COMPANY OVERVIEW
  • TABLE 378 MEDBLAZE (INFINI): COMPANY OVERVIEW
  • TABLE 379 ETASKPRO: COMPANY OVERVIEW
  • TABLE 380 QUALITYZE: COMPANY OVERVIEW
  • TABLE 381 KARMINN CONSULTANCY NETWORK: COMPANY OVERVIEW
  • TABLE 382 MEG: COMPANY OVERVIEW

List of Figures

  • FIGURE 1 HEALTHCARE QUALITY MANAGEMENT MARKET SEGMENTATION & REGIONAL SCOPE
  • FIGURE 2 RESEARCH DESIGN
  • FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
  • FIGURE 4 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING
  • FIGURE 5 BOTTOM-UP APPROACH
  • FIGURE 6 TOP-DOWN APPROACH
  • FIGURE 7 CAGR PROJECTIONS FROM ANALYSIS OF MARKET DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF HEALTHCARE QUALITY MANAGEMENT (QMS) INDUSTRY
  • FIGURE 8 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
  • FIGURE 9 DATA TRIANGULATION METHODOLOGY
  • FIGURE 10 HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY OFFERING, 2025 VS. 2030 (USD MILLION)
  • FIGURE 11 HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY FUNCTION, 2025 VS. 2030 (USD MILLION)
  • FIGURE 12 HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY USE CASE, 2025 VS. 2030 (USD MILLION)
  • FIGURE 13 HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY END USER, 2025 VS. 2030 (USD MILLION)
  • FIGURE 14 HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET: GEOGRAPHIC SNAPSHOT
  • FIGURE 15 GROWING REGULATORY REQUIREMENTS AND GOVERNMENT INITIATIVES TO DRIVE MARKET
  • FIGURE 16 SOFTWARE SEGMENT TO ACCOUNT FOR LARGEST MARKET SHARE IN 2025
  • FIGURE 17 INDIA TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD
  • FIGURE 18 ASIA PACIFIC TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD
  • FIGURE 19 DEVELOPING ECONOMIES TO REGISTER HIGHER GROWTH DURING FORECAST PERIOD
  • FIGURE 20 HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • FIGURE 21 US: ENGAGEMENT WITH AND FREQUENCY OF INTEROPERABLE EXCHANGE AMONG NON-FEDERAL ACUTE CARE HOSPITALS, 2018-2023
  • FIGURE 22 PATIENT-GENERATED HEALTH DATA USE CASE
  • FIGURE 23 HEALTHCARE DATA BREACHES (2009-2025)
  • FIGURE 24 INDIVIDUALS AFFECTED BY HEALTHCARE DATA BREACHES (2009-2025)
  • FIGURE 25 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
  • FIGURE 26 HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET: VALUE CHAIN ANALYSIS
  • FIGURE 27 HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET: ECOSYSTEM ANALYSIS
  • FIGURE 28 HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET: INVESTMENT & FUNDING SCENARIO
  • FIGURE 29 JURISDICTION ANALYSIS OF TOP APPLICANT COUNTRIES FOR HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET (2025)
  • FIGURE 30 HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET: TOP PATENT OWNERS/PATENTING TRENDS, 2015-2025
  • FIGURE 31 HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET: PORTER'S FIVE FORCES ANALYSIS
  • FIGURE 32 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY END USER
  • FIGURE 33 KEY BUYING CRITERIA FOR END USERS
  • FIGURE 34 MARKET POTENTIAL OF AI/GEN AI ON HEALTHCARE QUALITY MANAGEMENT (QMS) ACROSS INDUSTRIES
  • FIGURE 35 IMPACT OF AI/GEN AI ON INTERCONNECTED AND ADJACENT ECOSYSTEMS
  • FIGURE 36 NUMBER OF US HOSPITALS, BY TYPE (2025)
  • FIGURE 37 US HEALTH INSURANCE INDUSTRY (DIRECT HALTH PREMIUM), 2024
  • FIGURE 38 NORTH AMERICA: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET SNAPSHOT
  • FIGURE 39 ASIA PACIFIC: HEALTHCRE QUALITY MANAGEMENT (QMS) MARKET SNAPSHOT
  • FIGURE 40 REVENUE ANALYSIS OF KEY PLAYERS IN HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, 2020-2024
  • FIGURE 41 MARKET SHARE ANALYSIS OF KEY PLAYERS IN HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET (2024)
  • FIGURE 42 HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS
  • FIGURE 43 EV/EBITDA OF KEY VENDORS
  • FIGURE 44 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS
  • FIGURE 45 HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET: COMPANY EVALUATION QUADRANT (KEY PLAYERS), 2024
  • FIGURE 46 HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET: COMPANY FOOTPRINT
  • FIGURE 47 HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2024
  • FIGURE 48 NUANCE COMMUNICATIONS, INC. (MICROSOFT): COMPANY SNAPSHOT (2025)
  • FIGURE 49 PREMIER INC.: COMPANY SNAPSHOT (2025)
  • FIGURE 50 OPTUM, INC. (UNITEDHEALTH GROUP): COMPANY SNAPSHOT (2024)
  • FIGURE 51 INTELEX TECHNOLOGIES (FORTIVE): COMPANY SNAPSHOT (2024)
  • FIGURE 52 DNV: COMPANY SNAPSHOT (2024)
  • FIGURE 53 NAVEX GLOBAL, INC. (GOLDMAN SACHS): COMPANY SNAPSHOT (2024)